National Institutes of Health
Overview: The National Institutes of Health Climate Change and Health Initiative is seeking to bring Climate and Health scientists from outside the U.S. federal government to work with NIH staff to share knowledge and help build our capacity in the scientific domains outlined in the NIH Climate Change and Health Initiative’s Strategic Framework. Program Details: Climate and Health (CH) Scholars
June 08, 2022The COVID-19 pandemic continues to present considerable public health challenges in the United States and around the globe. One of the most puzzling is why many people who get over an initial and often relatively mild COVID illness later develop new and potentially debilitating symptoms. These symptoms run the gamut including fatigue, shortness of breath, brain fog, anxiety, and gastrointestinal
June 03, 2022A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths. Some COVID-19 patients experience an immune
-National Institutes of HealthWednesday, February 9, 2022, 12:00 PM - 1:00 PM NIEHS Virtual Security: Measures for Visitors to NIEHS Event Type: Virtual Event Contact: Voelker, Kerri: kerri.voelker@nih.gov, 919-794-4710 Principal Speaker: Robert D. Bullard, Ph.D., Texas Southern University Speaker Title: Distinguished Professor of Urban Planning and Environmental Policy Link: https://calendar.niehs.nih.gov/MasterCal_Public
-National Institutes of HealthEach year, NCATS and the NIH Clinical Center sponsor Rare Disease Day to raise awareness about rare diseases and the NIH collaborations that address scientific challenges and advance research for new treatments. This year’s virtual event will feature panel discussions, rare disease stories, exhibitors and scientific posters. A new event app will be available with enhanced engagement features and easier ways to connect with others.
The NEPTUNE Career Development program is designed to support advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease.
-National Institutes of HealthOn December 17, 2021 at 12:00 - 1:00 p.m. (ET), NINR will host “Notes from the Field: Pivoting a Research Program to Climate Change,” part of the NIH Climate Change and Health Webinar Series. Welcome remarks - Shannon Zenk, PhD, MPH, RN, FAAN, NINR Speaker - Director Linda A. McCauley, PhD, RN, Emory University, Nell Hodgson Woodruff School of Nursing, Climate Change and Nursing Research Nurse
-National Institutes of HealthJoin the NIH Office of Behavioral and Social Sciences Research (OBSSR) virtually on Thursday, November 18 and Friday, November 19, from 1:00 p.m. to 4:30 p.m. EST each day, for the annual NIH Behavioral and Social Sciences Research (BSSR) Festival. Register to attend and view the festival agenda and speaker biographies: https://www.scgcorp.com/obssrfest2021/Registration The festival, hosted by
-National Institutes of HealthBackground About one-fifth of all people in the United States live in rural areas. Health disparities continue to be a pressing issue for rural communities, where there are increased mortality rates, a higher prevalence of diseases, and lower life expectancy than in urban areas. While the underlying causes of such disparities are complex, social determinants of health (e.g., access to care
-National Institutes of HealthBackground Nutrition plays an important role throughout our lives in promoting health and preventing disease. But where we live or how much money we earn can affect our ability to access or afford healthy food choices. Ensuring food security and access to healthy food are key to preventing disparities in a variety of diet-related diseases and conditions, such as cardiovascular disease, obesity-
Pilot Grant Program for Myasthenia Gravis
Objectives: MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development. The priorities of the Pilot Grant Program are:
-National Institutes of HealthThe National Institutes of Health and the White House Office of Science and Technology Policy are organizing a series of listening sessions to get feedback from patient advocacy groups, industry, scientific professional organizations, and other stakeholders. These listening sessions will vary in format from broad, public discussions to smaller, invitation-only meetings to discuss more sensitive
-National Institutes of HealthFree registration now open! HHS Small Business Program Conference April 26-30 Calling all small business developers of products or services with the potential to improve human health! Free registration is now open for the 2021 HHS Small Business Program Conference, which is being held virtually from April 26-30. This year’s conference will explore the theme Diverse Perspectives SEEDing Impactful
-National Institutes of HealthThis RCCN Virtual Workshop will include sessions on aspects of including older adults in clinical research including the Current Situation, Barriers - Real and Perceived, Making the Case, and Best Practices Reaching for Out to Colleagues. View the draft agenda for the workshop here. This workshop will be held as a webinar, and registration is free and open to the public. Please register using this
-National Institutes of HealthNIMHD will host Dr. L. Ebony Boulware as the next NIMHD Director’s Seminar Series titled “Where Clouds Meet the Ground: Democratizing Health Data to Address Community Health Equity.” Dr. Boulware is the Eleanor Easley Chair at the School of Medicine and the chief of the Division of General Internal Medicine at the Department of Medicine at Duke University. As a general internist and clinical
-National Institutes of HealthRegistration for Rare Disease Day at NIH (RDD at NIH) 2021 is now open! RDD at NIH, sponsored by NCATS and the NIH Clinical Center, will take place virtually on March 1, 2021, from 10:30 a.m. to 5:30 p.m. EST. Each year, NIH hosts this event to raise awareness about rare diseases, the people they affect and research collaborations underway to address scientific challenges and to advance new
December 04, 2020Has your school made an important contribution to helping women become leaders in their field? Maybe your department made noticeable strides recently in diversifying the gender and race or ethnicity of its workforce? What about your institution’s response to reversing the “backward slide” experienced by women in biomedicine because of COVID-19? Well, tell us about it! Your institution could
Vasculitis refers to a group of rare diseases that involve inflammation of blood vessels, which disrupts blood flow and often causes damage to the body’s organs. The cause of most forms of vasculitis remains unknown, and treatments involve the use of strong medications that can have serious side effects. The Vasculitis Clinical Research Consortium (VCRC) is an international, multicenter clinical
The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) focuses on several inherited and acquired disorders that cause thickened, infected secretions to accumulate in the upper and lower airways. Its work is conducted at eight clinical research sites across the United States and Canada. During the past 15 years, the consortium has made numerous advances that profoundly changed clinical
Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis are disorders in which a type of immune cell (called eosinophils) builds up in the digestive tract, causing gastrointestinal tissue damage. These disorders are painful, lifelong, and make it hard or impossible for people to eat many or all foods. The Consortium of Eosinophilic Gastrointestinal
November 23, 2020What does a scientist look like? Whose face comes to mind? Meet 10 young scientists from across the country pursuing careers in biomedical research! #FaceOfScience is diverse, fresh, bold, unique and unapologetic! Join us today on #NationalSTEMDay to celebrate diversity in STEM and re-envision #WhatAScientistLooksLike. What:The Diversity Program Consortium (DPC) is a network of institutions
-National Institutes of HealthThe National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) are co-hosting a virtual Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy. This meeting will bring together scientists-
-National Institutes of HealthJoin NCATS and the National Institute on Minority Health and Health Disparities for the 2020 NIH Rural Health Seminar: Challenges in the Era of COVID-19. The seminar will bring together researchers, medical practitioners and others to explore topics in rural health. Learn about the impact of COVID-19 on rural populations, on systems and workforce issues, and on community engagement in response to
-
-National Institutes of HealthNov. 18-19, 2020 Day 1: 8:30 a.m. to 5:30 p.m. EST Day 2: 8:50 a.m. to 5 p.m. EST NCATS is hosting a two-day workshop that will cover a broad range of critical concepts underlying assay development and implementation for high-throughput screening and lead discovery projects. This workshop is designed to disseminate critical information about the implementation of robust assay methods and is
-
-National Institutes of HealthNCATS and the National Institute of Allergy and Infectious Diseases (NIAID) are sponsoring this scientific summit to discuss progress and remaining challenges in developing antiviral treatments for COVID-19. Scientific experts from public and private sectors will examine such topics as SARS-CoV-2 targets for drug development and tools to test promising antiviral drug candidates. They also will
-National Institutes of HealthDate and Time: Thursday, November 19, 2020 from 1:00 p.m. – 5:00 p.m. ET Location: NIH Videocast The virtual event is FREE and open to the public. Registration is required. Agenda: View, print, or download a detailed agenda (PDF, 207 KB) Speaker Biographies: View, print, or download speaker biographies (PDF, 507 KB) About the Seminar: Today, approximately 20% of the U.S. population—about 60-
THE POSITION: NCI is seeking an innovative leader to serve as its Associate Director for Informatics & Data Science, Center for Biomedical Informatics and Information Technology (CBIIT). The NCI is the principal agency of the Federal Government for cancer research and for carrying out the National Cancer Program. CBIIT accelerates cancer research by empowering scientists and clinicians with the
Autism spectrum disorder (ASD) affects 1 in 59 children in the United States and is a major public health concern and challenge. The Developmental Synaptopathies Consortium (DSC) aims to explore the underlying causes of autism by focusing on three rare genetic disorders related to ASD, including Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Tumor Syndrome (PHTS) and Phelan-McDermid Syndrome-
The NIH-funded Restore Center is seeking proposals for pilot projects that accelerate the use of sensor and video technology in rehabilitation research and will advance real-world monitoring and delivery of medical rehabilitation.
Funding: Up to $30,000 over a one-year period
-National Institutes of HealthThe Office of Data Science Strategy at the National Institutes of Health (NIH) and the National Library of Medicine are hosting a virtual workshop on Jumpstarting Clinical Data Access to COVID-19 Research on July 29, 2020. NIH is committed to advancing research and its data science efforts to end the COVID-19 pandemic. As part of the larger NIH COVID-19 response, leadership is designing a COVID-19